PNTG Pennant Group, Inc.

Nasdaq Services-Health Services DE CIK: 0001766400
AI RATING
SELL
78% Confidence

Investment Thesis

Pennant Group exhibits strong revenue growth of 36.3% YoY, but this growth masks deteriorating fundamentals: net income declined 12.4% YoY despite revenue expansion, indicating significant margin compression and operational challenges. Most critically, the company generated negative operating cash flow of -$3.4M and negative free cash flow of -$8.7M, which is unsustainable and suggests working capital deterioration or operational distress despite positive net income.

Strengths

  • + Strong revenue growth of 36.3% YoY demonstrates market demand and scale expansion
  • + Reasonable leverage profile with Debt/Equity ratio of 0.42x and strong interest coverage of 9.7x
  • + Positive net income of $8.5M shows the business is currently profitable on an accrual basis

Risks

  • ! Negative operating cash flow of -$3.4M and negative free cash flow of -$8.7M are unsustainable and indicate operational distress despite positive earnings
  • ! Net income declining 12.4% YoY while revenue grows 36.3% reveals severe margin compression and loss of profitability quality
  • ! Extremely low profitability margins (3.0% net margin, 6.1% operating margin) combined with poor returns (ROE 2.2%, ROA 0.9%) suggest structural operational challenges
  • ! Critically low cash position of only $4.9M against $164.7M long-term debt makes the company vulnerable to cash flow disruptions

Key Metrics to Watch

Financial Metrics

Revenue
285.4M
Net Income
8.5M
EPS (Diluted)
$0.24
Free Cash Flow
-8.7M
Total Assets
956.5M
Cash
4.9M

Profitability Ratios

Gross Margin N/A
Operating Margin 6.1%
Net Margin 3.0%
ROE 2.2%
ROA 0.9%
FCF Margin -3.0%

Balance Sheet & Liquidity

Current Ratio
1.19x
Quick Ratio
1.19x
Debt/Equity
0.42x
Debt/Assets
59.3%
Interest Coverage
9.65x
Long-term Debt
164.7M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-07T10:14:04.451176 | Data as of: 2026-03-31 | Powered by Claude AI